Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00544_nanopub.RATHE6VZapfd-aO7OVIF6jQdvpAJ7MdKS9ZX31uX2Nogo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00544 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00544 label "DDI between Trimethoprim and Fluorouracil - The strong CYP2C9 inhibitor, Fluorouracil, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Fluorouracil is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00544]" assertion.
- drugbank_resource:DB00440_DB00544 identifier "drugbank_resource:DB00440_DB00544" assertion.
- drugbank_resource:DB00440_DB00544 title "DDI between Trimethoprim and Fluorouracil - The strong CYP2C9 inhibitor, Fluorouracil, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Fluorouracil is initiated, discontinued or dose changed." assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00544 assertion.
- drugbank:DB00544 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00544 assertion.